Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2313338
Max Phase: Preclinical
Molecular Formula: C40H40N6O10S
Molecular Weight: 796.86
Molecule Type: Small molecule
Associated Items:
ID: ALA2313338
Max Phase: Preclinical
Molecular Formula: C40H40N6O10S
Molecular Weight: 796.86
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)nn2)[C@H]1O
Standard InChI: InChI=1S/C40H40N6O10S/c47-21-31-35(49)33(45-19-29(41-43-45)23-11-15-27(16-12-23)53-25-7-3-1-4-8-25)37(51)39(55-31)57-40-38(52)34(36(50)32(22-48)56-40)46-20-30(42-44-46)24-13-17-28(18-14-24)54-26-9-5-2-6-10-26/h1-20,31-40,47-52H,21-22H2/t31-,32-,33+,34+,35+,36+,37-,38-,39+,40+/m1/s1
Standard InChI Key: ALXHMOBVFGATLU-YXBMSDDCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 796.86 | Molecular Weight (Monoisotopic): 796.2527 | AlogP: 3.18 | #Rotatable Bonds: 12 |
Polar Surface Area: 219.72 | Molecular Species: NEUTRAL | HBA: 17 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.52 | CX Basic pKa: 0.06 | CX LogP: 3.76 | CX LogD: 3.76 |
Aromatic Rings: 6 | Heavy Atoms: 57 | QED Weighted: 0.10 | Np Likeness Score: -0.13 |
1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ.. (2013) Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1., 56 (3): [PMID:23281927] [10.1021/jm301677r] |
Source(1):